MIST Stock Summary and Trading Ideas (Milestone Pharmaceuticals - Common Shares | NASDAQ:MIST)

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Milestone Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol MIST.

As of April 15, 2026, MIST stock price climbed to $2.13 with 1,404,166 million shares trading.

MIST has a beta of 3.25, meaning it tends to be more sensitive to market movements. MIST has a correlation of 0.25 to the broad based SPY ETF.

MIST has a market cap of $250.63 million. This is considered a Small Cap stock.

Last quarter Milestone Pharmaceuticals - Common Shares reported $2 million in Revenue and -$.16 earnings per share. This beat revenue expectation by $346,000 and exceeded earnings estimates by $.02.

In the last 3 years, MIST traded as high as $4.49 and as low as $.63.

The top ETF exchange traded funds that MIST belongs to (by Net Assets): QQQS, GWX.

MIST has outperformed the market in the last year with a price return of +156.1% while the SPY ETF gained +30.7%. MIST has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +4.9% and +79.0%, respectively, while the SPY returned +1.3% and +7.3%, respectively.

MIST support price is $1.89 and resistance is $2.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MIST shares will trade within this expected range on the day.